Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anfarm is a prominent Greek pharmaceutical company founded in 1967, specializing in the development and manufacture of generic pharmaceutical products. The company is recognized as a significant European Contract Development and Manufacturing Organization (CDMO), particularly known for its expertise in sterile injectable forms and antibiotics. Anfarm operates multiple EU-GMP certified manufacturing sites, including dedicated facilities for cephalosporins and penicillins. Their business model encompasses the production of their own branded generics as well as providing comprehensive manufacturing services for international pharmaceutical partners. With a strong export orientation, Anfarm distributes its products to more than 25 countries worldwide, focusing on therapeutic areas such as cardiology, gastroenterology, and the central nervous system.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anfarm.